GlassScriptPhysician profile
Julia Gibbons
NPI 1700439288
$1,304.68
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,272 · 2024: $32.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $273.59 | 2021-2024 | |
| Kaleo, INC. | $189.72 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $178.97 | 2021 | |
| Csl Behring | $150.74 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $107.76 | 2021 | |
| Octapharma USA, INC. | $102.55 | 2021 | |
| Glaxosmithkline, LLC. | $86.38 | 2021 | |
| Grifols USA, LLC | $77.97 | 2021 | |
| Novartis Pharmaceuticals Corporation | $59.36 | 2021 | |
| Genzyme Corporation | $44.98 | 2021 | |
| Genentech USA, INC. | $18.57 | 2021 | |
| Pfizer INC. | $14.09 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Gibbons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.